What Boehringer Ingelheim Pharmaceuticals, Inc. pays on H-1B filings

Boehringer Ingelheim Pharmaceuticals, Inc. filed 66 certified H-1B LCAs in FY2025-FY2026. Each one states the wage the employer will pay for a role at a worksite. Grouped by title below: what the employer stated, not what any one person earned.

FY2026 so far · 26 LCAsFY2025 · 40 LCAs

Stated wages by title

TitleLCAsYearTypical rangeMedian
Clinical Data Scientist10FY2026 so far$148,748 to $164,223$157,903
Scientist10FY2026 so far$140,500 to $145,000$142,000
Associate Director6FY2026 so far$173,825 to $181,515$177,727
Scientist Process Research6FY2025$128,000 to $157,524$130,000
Post Doctoral Iu Fellow4FY2026 so far$80,000 to $81,250$80,000
Post Doctoral Fellow3FY2025$80,000$80,000

Typical range is the middle half of that year's filings, or the full span when there are fewer than four. LCA counts cover FY2025-FY2026.

Filings by fiscal year

Fiscal yearCertified LCAs
FY2026 (October to June)26
FY202540

By prevailing-wage level

LevelLCAsMedian stated wage
Level I (entry)4$80,000
Level II (qualified)19$130,000
Level III (experienced)12$156,755
Level IV (fully competent)30$168,138
No level stated1$151,621

DOL sets four prevailing-wage levels for each job and place, from entry (I) to fully competent (IV). The level is the employer's own classification of the position.

Top worksites

WorksiteLCAsMedian stated wage
Ridgefield, CT47$155,920
Danbury, CT1$150,000

Looking at Boehringer Ingelheim Pharmaceuticals, Inc.?

Nyanza shows these filings next to any posting you check, with the employer's H-1B approval history, so you can ask the right questions early.